From: The prognostic value of dynamic changes in SII for the patients with STEMI undergoing PPCI
 | The event(n = 39) | non-the event(n = 285) | t/χ2/z | P value |
---|---|---|---|---|
Gender | Â | Â | Â | Â |
 Male, n(%) | 33(84.62) | 218(76.49) | 1.297 | 0.255 |
 Female, n(%) | 6(15.38) | 67(23.51) | ||
 Age, n(%) | 69(20) | 66(17) | −0.382 | 0.702 |
Chest pain period(h) | 6(5.5) | 4(4) | −2.070 | 0.038a |
Pain-to-balloon time(h) | 7.1(6.5) | 5.35(4.43) | −2.283 | 0.022a |
Door-to-balloon time(h) | 1(0.58) | 1(0.61) | −0.785 | 0.433 |
hospitalization day(d) | 6(2) | 6(2) | −0.148 | 0.882 |
History | Â | Â | Â | Â |
Hypertension,n(%) | 18(46.15) | 117(41.05) | 0.367 | 0.544 |
Diabetes mellitus,n(%) | 9(23.08) | 56(19.65) | 0.251 | 0.616 |
Stroke or TIA,n(%) | 6(15.38) | 28(9.82) | 0.615 | 0.433 |
Previous MI/PCI/CABG,n(%) | 3(7.69) | 16(5.61) | 0.024 | 0.877 |
Heart Failure,n(%) | 3(7.69) | 7(2.46) | 1.638 | 0.201 |
Coronary heart disease,n(%) | 6(15.38) | 29(10.18) | 0.501 | 0.479 |
Current smoking status,n(%) | 11(28.21) | 100(35.09) | 0.722 | 0.396 |
Current drinking status,n(%) | 8(20.51) | 52(18.25) | 0.117 | 0.732 |
Admission medication | Â | Â | Â | Â |
Aspirin,n(%) | 39(100.00) | 285(100.00) | – | – |
Clopidogrel or Tigrigrel,n(%) | 39(100.00) | 285(100.00) | – | – |
ACEIs or ARBs,n(%) | 19(48.72) | 164(57.54) | 1.087 | 0.297 |
CCB,n(%) | 16(41.03) | 135(47.37) | 0.555 | 0.456 |
Î’-blocker,n(%) | 34(87.18) | 254(89.12) | 0.008 | 0.928 |
Statin,n(%) | 39(100.00) | 285(100.00) | – | – |
Diuretics,n(%) | 18(46.15) | 95(33.33) | 2.483 | 0.115 |
SBP (mmHg) | 119(30) | 123(29) | −1.840 | 0.066 |
DBP (mmHg) | 72(14) | 78(18) | −1.544 | 0.123 |
Heart-rate (beats-per-minute) | 83.28 ± 14.84 | 80.70 ± 14.10 | 0.018 | 0.287 |
Killip class,n(%) | Â | Â | Â | Â |
 1–2 | 30(76.92) | 263(92.28) | 7.661 | 0.006a |
 3–4 | 9(23.08) | 22(7.72) | ||
Target Vessel,n(%) | Â | Â | Â | Â |
 LM | 3(7.69) | 6(2.11) | 2.166 | 0.141 |
 LAD | 25(64.10) | 166(58.25) | 0.486 | 0.486 |
 LCX | 6(15.38) | 31(10.88) | 0.315 | 0.574 |
 RCA | 7(17.95) | 88(30.88) | 2.767 | 0.096 |
Simultaneous treatment of vascular situations,n(%) | Â | Â | Â | Â |
 1 | 37(94.87) | 279(97.89) | 0.349 | 0.555 |
  > 1 | 2(5.13) | 6(2.11) | ||
Vessel-disease (stenosis > 50%) |  |  |  |  |
 1 vessel,n(%) | 11(28.21) | 79(27.72) | 0.004 | 0.949 |
 2 vessels,n(%) | 15(38.46) | 66(23.16) | 3.508 | 0.061 |
 3 vessels,n(%) | 13(33.33) | 140(49.12) | 3.432 | 0.064 |
PCI type,n(%) | Â | Â | Â | Â |
Only PTCA | 5(12.82) | 30(10.53) | 0.025 | 0.875 |
PTCA and Stent | 34(87.18) | 255(89.47) | ||
Stent type,n(%) | Â | Â | Â | Â |
 Drug eluting stent | 10(25.64) | 119(41.75) | 3.717 | 0.054 |
 Bare metal stent | 29(74.36) | 166(58.25) | ||
Number of stents inserted,n(%) | Â | Â | Â | Â |
1 piece | 32(82.05) | 261(91.58) | 2.582 | 0.108 |
≥2 piece | 7(17.95) | 24(8.42) | ||
Stent length (mm) | 28(6) | 23(11) | −1.995 | 0.046a |
Stent Diameter (mm) | 3(0.25) | 3(0.5) | −0.531 | 0.595 |
IVUS Assist,n(%) | Â | Â | Â | Â |
Yes | 3(7.69) | 10(3.51) | 0.662 | 0.416 |
No | 36(92.31) | 275(96.49) | ||
TIMI after PPCI n(%) | Â | Â | Â | Â |
3 | 37(94.87) | 279(97.89) | 0.349 | 0.555 |
<3 | 2(5.13) | 6(2.11) | ||
site of AMI n(%) | Â | Â | Â | Â |
anterior | 25(64.10) | 145(50.88) | 6.695 | 0.112 |
 antero-septal | 1(2.56) | 9(3.16) | ||
 high side wall | 2(5.13) | 3(1.05) | ||
 Inferior wall | 11(28.21) | 125(43.86) | ||
 anterolateral | 0(0.00) | 3(1.05) |